Repros Therapeutics Inc.

EX-1.1

from 8-K 34 pages Repros Therapeutics, Inc. 2,744,125 Shares of Common Stock Series a Warrants to Purchase 3,742,500 Shares of Common Stock Series B Warrants to Purchase 2,495,000 Shares of Common Stock Pre-Funded Series C Warrants to Purchase 2,245,875 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1.1

from 8-K 25 pages Repros Therapeutics Inc. $10,000,000 of Common Stock ($0.001 Par Value Per Share) Equity Distribution Agreement

12/34/56

EX-1.1

from 8-K 50 pages Repros Therapeutics Inc. (A Delaware Corporation) 3,750,000 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1.1

from 8-K 24 pages Placement Agency Agreement

12/34/56

EX-1.1

from 8-K 35 pages 690,000 Units Repros Therapeutics Inc. Each Unit Consisting of 4 Shares of Common Stock and 3 Series a Warrants and 2.45 Series B Warrants Underwriting Agreement February 3, 2011

12/34/56

EX-1.1

from S-1/A 35 pages [ ] Units Repros Therapeutics Inc. Each Unit Consisting of [ ] Shares of Common Stock and [ ] Series a Warrants and [ ] Series B Warrants Underwriting Agreement [ ], 2011

12/34/56

EX-1

from SC 13D ~5 pages Joint Filing Agreement

12/34/56

EX-1